Recombinant human VHL protein

Produktübersicht

• Artikelname: Recombinant human VHL protein
• Artikelnummer: NBS-PAT-VFZ8HD-100
• Hersteller Artikelnummer: PAT-VFZ8HD-100
• Alternativnummer: NBS-PAT-VFZ8HD-100
• Hersteller: Nordic BioSite
• Kategorie: Proteine/Peptide
• Applikation: EP
• Spezies Reaktivität: Human
• Alternative Synonym: Von Hippel-Lindau tumor suppressor isoform 1, Von Hippel-Lindau tumor suppressor isoform 1, HRCA1, RCA1, VHL1, Von Hippel-Lindau tumor suppressor isoform 1 pVHL, G7 protein, Elongin binding protein, HRCA 1, RCA 1, VHL, VHL 1, VHLH, Von Hippel Lindau dise

Produktbeschreibung

Von Hippel-Lindau disease (VHL) is a dominant inherited syndrome characterized by the predisposition to develop various kinds of benign and malignant tumors, including clear cell renal carcinomas, pheochromocytomas and hemangioblastomas of the central ne

Produkteigenschaften

• Konzentration: 1 mg/ml
• Molekulargewicht: 19.2 kDa (174aa) confirmed by MALDI-TOF
• Tag: HIS Tag
• NCBI: 7428
• UniProt: P40337
• Puffer: Liquid. In phosphate-buffered Saline (pH 7.4) containing 1mM DTT, 2mM EDTA
• Reinheit: >85%
• Sequenz: MPRRAENWDE AEVGAEEAGV EEYGPEEDGG EESGAEESGP EESGPEELGA EEEMEAGRPR PVLRSVNSRE PSQVIFCNRS PRVVLPVWLN FDGEPQPYPT LPPGTGRRIH SYRGHLWLFR DAGTHDGLLV NQTELFVPSL NVDGQPIFAN ITLP